Plenary: Prime Time, Friday

Plenary: Prime Time

Court is in Session: Sepsis after Mini-PCNL

Friday, May 12
3:00 PM - 3:50 PM
Location: BCEC: Ballroom West

Zeph Okeke, MD

Hofstra Northwell School of Medicine

Presentation(s):

Send Email for Zeph Okeke

Stephen Y. Nakada, MD, FACS

University of Wisconsin-Madison

Dr. Nakada is certified by the American Board of Urology. He is an internationally renowned expert in urinary stones disease(urolithiasis) and minimally invasive urology. In 1997, he performed and reported the first hand-assisted laparoscopic nephrectomy, in the United States, using a sleeve. In 2001, he was named Chairman of Urology and the first David T. Uehling Chair and Professor of Urology.

In 2003, Dr. Nakada became the 15th Dornier/A.F.U.D. Award Winner for Innovative Research in Urology. He was the 2004 recipient of the Gold Cystoscope Award from the American Urological Association. Dr. Nakada has served on both the Staghorn Stone Guidelines Committee and the Distal Stones Guidelines Panel of the American Urological Association. He is listed in Best Doctors in America, Castle Connelly’s Top Doctors, and Madison Magazine’s Top Docs.

Dr. Nakada has authored or coauthored over 200 scientfic articles and 50 book chapters, and he has edited 9 textbooks. He has served on the ABU/AUA Examination Committee as well as editorial boards for Urology, the Journal of Endourology and Urology Times. Dr. Nakada is the President of the Endourology Society and the SAU, and he is formerly a member of the AUA Board of Directors. Dr. Nakada is a member of the American Association of Genitourinary Surgeons and the Clinical Society of Genitourinary Surgeons, among other societies. Dr. Nakada is also President Elect of the American Board of Urology.

Presentation(s):

Send Email for Stephen Nakada

Glenn M. Preminger, MD

Duke University Medical Center

Glenn M. Preminger, MD Professor at Duke University Medical Center, completed his Urologic training at the University of North Carolina in 1983. He was an AUA Scholar (1983-1985) in Mineral Metabolism at UT Southwestern Medical Center, concentrating on the medical management of nephrolithiasis. He spent 10 years on the Faculty in Dallas, returning to NC in 1993 as Professor of Urologic Surgery and Director of the Comprehensive Kidney Stone Center at Duke .
His clinical interests include the minimally invasive management of urinary tract stones including SWL, percutaneous and ureteroscopic stone removal. He directs the metabolic evaluation and preventative medical treatment offered at the Duke Comprehensive Kidney Stone Center.
He has had extensive experience in the development of endoscopic instrumentation for minimally invasive urologic procedures and holds eight patents in shock wave lithotripsy design. Dr. Preminger, along with Pei Zhong, Ph.D., established The Lithotripsy Laboratory within the Comprehensive Kidney Stone Center to study shock wave physics and tissue effects within the realms of shock wave lithotripsy and intracorporeal lithotripsy devices. Drs. Preminger and Zhong have been awarded over $10 million in research support from the National Institutes of Health.
Dr. Preminger has published more than 350 manuscripts, 100 book chapters and 10 books, as well as 30 videos that review complex endoscopic techniques. He is a member of 15 professional societies and holds Editorial positions with UROLOGY and the JOURNAL OF ENDOUROLOGY. He has served as Co-Chairman of VIII International Symposium on Urolithiasis (1996) and Co-Chairman of the 1st and 2nd International Consultations on Stone Disease, (2001 & 2007). He was Chairman of the AUA Nephrolithiasis Guidelines Panel, which released four sets of guidelines for the management of staghorn calculi (1994, 2004) and ureteral calculi (1997, 2007). From 2004-2007, he was Co-Chairman of the joint AUA/EAU International Nephrolithiasis Guidelines Panel.

Presentation(s):

Send Email for Glenn Preminger

Ojas Shah, MD

Columbia University Irving Medical Center

Dr. Ojas Shah is Professor of Urology and Director of the Division of Endourology and Stone Disease at Columbia University Irving Medical Center. His clinical interests include surgical and metabolic treatments of kidney stone disease, minimally invasive urologic surgery, upper tract transitional cell carcinoma/urothelial carcinoma, ureteral strictures, ureteropelvic junction (UPJ) obstruction, ureteral/renal reconstructive surgery, and BPH (benign prostate hyperplasia).

He is a graduate of Northwestern University School of Medicine. He completed his general surgical and urologic training at New York University Medical Center. He spent an additional year at Wake Forest University Health Sciences Center as a fellow in endourology, laparoscopy and metabolic stone disease.

Dr. Shah is nationally active as a member of the American Urological Association Surgical Management of Stones Guidelines Committee. He serves as an Assistant Editor to the Journal of Urology and is Associate Editor for the 5th edition of Taneja's Complications of Urologic Surgery. He also has a strong focus on medical student and resident education, and served as the urology residency program director at NYU prior to joining Columbia.

Presentation(s):

Send Email for Ojas Shah


Assets

Court is in Session: Sepsis after Mini-PCNL



Attendees who have favorited this

Send Email for Court is in Session: Sepsis after Mini-PCNL